Fast Five Quiz: Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)

Karl J. D'Silva, MD


June 23, 2020

The NOTCH1 and SF3B1 mutations are predictors of shorter survival in patients with relapsed or refractory CLL. These mutations are also predictors of shorter survival in patients who have been newly diagnosed with CLL.

Learn more about chromosomal testing and CLL.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as: